Drug Type T-lymphocyte cell therapy |
Synonyms- |
Target- |
Action- |
Mechanism T lymphocyte replacements |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Lymphoblastic Leukemia | Phase 2 | United States | 31 Dec 2021 | |
Acute Myeloid Leukemia | Phase 2 | United States | 31 Dec 2021 | |
Refractory Acute Leukemia | Phase 2 | United States | 31 Dec 2021 |